key: cord-0690438-6v0y6xsa authors: Akaike, T; Maeda, H title: Nitric oxide and virus infection date: 2000-11-01 journal: Immunology DOI: 10.1046/j.1365-2567.2000.00142.x sha: bd1d562cb24b73a74830ca23e2c0cd02e609c8cb doc_id: 690438 cord_uid: 6v0y6xsa Nitric oxide (NO) has complex and diverse functions in physiological and pathophysiological phenomena. The mechanisms of many events induced by NO are now well defined, so that a fundamental understanding of NO biology is almost established. Accumulated evidence suggests that NO and oxygen radicals such as superoxide are key molecules in the pathogenesis of various infectious diseases. NO biosynthesis, particularly through expression of an inducible NO synthase (iNOS), occurs in a variety of microbial infections. Although antimicrobial activity of NO is appreciated for bacteria and protozoa, NO has opposing effects in virus infections such as influenza virus pneumonia and certain other neurotropic virus infections. iNOS produces an excessive amount of NO for long periods, which allows generation of a highly reactive nitrogen oxide species, peroxynitrite, via a radical coupling reaction of NO with superoxide. Thus, peroxynitrite causes oxidative tissue injury through potent oxidation and nitration reactions of various biomolecules. NO also appears to affect a host's immune response, with immunopathological consequences. For example, overproduction of NO in virus infections in mice is reported to suppress type 1 helper T-cell-dependent immune responses, leading to type 2 helper T-cell-biased immunological host responses. Thus, NO may be a host response modulator rather than a simple antiviral agent. The unique biological properties of NO are further illustrated by our recent data suggesting that viral mutation and evolution may be accelerated by NO-induced oxidative stress. Here, we discuss these multiple roles of NO in pathogenesis of virus infections as related to both non-specific inflammatory responses and immunological host reactions modulated by NO during infections in vivo. Free radical species with oxygen-or nitrogen-based unpaired electrons are now considered to play diverse roles in many aspects of physiological and pathological events. In the past decade, particular attention has been paid to the unique biological functions of nitric oxide (NO), a gaseous nitrogencentred inorganic radical that is produced endogenously in a number of cells and tissues. NO is critically involved in non-speci®c (innate) and immunological host defense. It has antimicrobial actions against various pathogens via its cytotoxic or cytostatic effects. 1±5 Potent host defence against intruding microbes is also mediated by oxygen radicals and active oxygen species, including superoxide anion radical (O 2 ± ), hydrogen peroxide (H 2 O 2 ), and hypochlorite anion (OCl ± ), produced from phagocytic cells such as neutrophils and activated macrophages. 6 It is now well accepted that the chemical and biological reactivities of NO produced in environments such as in¯amed tissues are greatly affected by concomitantly formed oxygen radicals, particularly O 2 ± , through formation of reactive nitrogen oxides such as peroxynitrite (ONOO ± ). 7±12 Although the importance of these reactive nitrogen and oxygen intermediate species has been documented for host defence reactions against bacteria and fungi, 1±5 their role in the pathogenesis of virus infections is only partly understood. Because pathological consequences of microbial infections are determined by the interaction of the host and the pathogen, a central theme in modern microbiology is overall understanding of the mechanism of host±pathogen interaction rather than gaining insight about a particular microbe. It is thus critical to evaluate the pathogenesis of virus infection as related to the emerging concept of free radicals that are generated as host-derived factors during interactions between viruses and hosts. 13±17 In this review, the biological relevance of NO production is discussed in view of oxidative stress and immunomodulation of the host's responses caused by NO during virus infections. Overproduction of NO, mainly caused by inducible NO synthase (iNOS), which is usually expressed by in¯ammatory phagocytic cells and other types of cells (e.g. epithelial and neuronal cells), has a defence function against bacteria, fungi, and parasites. 1±5,18 iNOS produces a much larger amount of NO for a longer time (i.e. 10±100 times more) than do the other two constitutive enzymes, neuronal NOS and endothelial NOS. 19, 20 Although NO seems to have a limited bactericidal effect, 21±23 suppression or lack of NO production results in impaired clearance of some types of bacteria by the host. 5,18,24±28 NOS is induced in a variety of experimental virus infections in rats and mice, including those with neuroviruses, such as Borna disease virus, herpes simplex virus type 1 (HSV-1), rabies virus, and pneumotropic and cardiotropic viruses, such as in¯uenza virus, Sendai virus, and coxsackievirus. 15,16,29±35 iNOS expression is also observed in human diseases caused by human immunode®ciency virus-1 (HIV-1) and hepatitis B virus (HBV). 36, 37 It seems therefore that iNOS is ubiquitously expressed during host responses to viral replication in vivo (Fig. 1a) . For example, iNOS is expressed by exudate macrophages and bronchial epithelial cells in lung tissues infected with in¯uenza virus in mice; the high output of NO has been clearly identi®ed and quanti®ed by electron spin resonance (ESR) spin trapping with the use of a dithiocarbamate-iron complex. 16, 34 NO-dithiocarbamate-iron adducts with a triplet hyper®ne structure of g perpendicular 2 . 04 are generated (Fig. 1b) , and their production is completely nulli®ed by pharmacological NOS inhibition with N v -monomethyl-L-arginine (L-NMMA) or by genetic disruption of iNOS, indicating that excessive production of NO is because of localized iNOS expression in the area of the virus infection. 16, 34 The time pro®le of iNOS induction in the lung correlates well with that of the pathological manifestations of the viral pneumonia, i.e. pulmonary consolidation characterized by extensive in®ltration of macrophages and lymphocytes, rather than that of viral replication in the lung. iNOS induction and NO production become maximum several days after viral yield peaks in the lung. The infected animals are moribund because of respiratory failure, which follows a transient and excessive NO production in the virus-infected lung. NO may thus be directly linked to the pathogenesis of viral pneumonia. Many pathological effects of NO are thought to be produced via its interaction with oxygen radicals, particularly O 2 ± , producing ONOO ± . 7±12 In this context, we analysed O 2 ± generation in virus-infected lung with a focus on xanthine oxidase (XO) as a potent generator of O 2 ± in the in¯uenza model. 38 O 2 ± production from XO in bronchoalveolar lavagē uid increases in a time-dependent manner with a time pro®le almost parallel to that of iNOS induction. 15, 16, 34, 38 To con®rm the generation of NO and O 2 ± , and their coupling reaction, in the local area of virus infection, ESR was used to measure NOhaemoglobin, which is formed de novo from the reaction of endogenous haemoglobin with NO generated in the virusinfected lung. The effect of an O 2 ± scavenger, a polymerconjugated Cu,Zn-superoxide dismutase (SOD), on the level of NO-haemoglobin production was also examined. A signi®cant increase in the NO-haemoglobin ESR signal in the lung is obtained by SOD treatment of virus-infected animals, possibly because an appreciable amount of NO is rescued from the quenching reaction with O 2 ± because of elimination of O 2 ± by SOD. 34 These results provide substantial evidence for ONOO ± formation in virus-infected tissues. iNOS induction in virus infection is mediated by pro-in¯ammatory cytokines such as interferon-c (IFN-c) (Fig. 1a) . Wild-type mice (C57BL/6, B6), iNOS heterozygotes (iNOS +/± ), and mice de®cient in iNOS (iNOS ±/± ) were inoculated with 2rLD 50 of in¯uenza virus, and ESR was performed as described previously. 34 In pneumonia induced by in¯uenza virus or Sendai virus, NO production is greatly attenuated in IFN-c-de®cient mice (Akaike et al., unpublished observation). Furthermore, the iNOS-inducing potential in bronchoalveolar lavage¯uid in in¯uenza virus pneumonia is attributable solely to IFN-c, as revealed by an immunoadsorption study using a speci®c anti-IFN-c antibody. 34 These results strongly support the suggestion that IFN-c is a major cytokine inducing iNOS and NO overproduction in pathogenesis of virus infection. 15, 16, 31 Many previous reports indicate that type 1 helper T cell (Th1) responses are important for viral clearance. 39±41 However, IFN-c, a Th1-dependent cytokine, seems to be inef®cient in host defence against various viral pathogens including in¯uenza virus, Sendai virus, and vaccinia virus. 42±44 In addition, lack of an iNOS-dependent antiviral effect is also noted for the same virus infections, which was recently con®rmed by a number of studies using iNOS-de®cient (iNOS ±/± ) mice. 44±48 Downregulation of iNOS expression is also reported for some cytokines, e.g. interleukin (IL)-4, IL-10, and transforming growth factor-b. 49±51 In addition, these suppressor cytokines may reduce NO production indirectly via induction of arginase, 52±54 which diminishes the supply of the substrate (L-arginine) for iNOS. Because IL-4 and IL-10 are induced by type 2 helper T cell (Th2) responses, iNOS expression may be regulated by a Th1±Th2 balance involved in the host immune response to the intruding virus. In fact, in our in¯uenza model, induction of IL-4 seems to be inversely related to IFN-c and iNOS induction in virus-infected lungs, suggesting downregulation by IL-4 of NO overproduction. 16 Induction of arginase I mRNA has been identi®ed in virus-infected lung, and the time pro®le of its induction paralleled to IL-4 induction (our unpublished observation). In some viral diseases, viral replication or viral components directly induce iNOS without mediation by pro-in¯ammatory cytokines (Fig. 1a) . iNOS expression in HIV-1 encephalitis is of particular interest in this regard. 36 An envelope glycoprotein of HIV, gp41, triggers iNOS expression in human astrocytes and murine cortical brain cells in culture. 55, 56 Thus, NO produced by iNOS may contribute directly to the pathogenesis of HIVassociated dementia and cardiomyopathy as well. 36, 57, 58 Similarly, the human paramyxovirus respiratory syncytial virus directly upregulates iNOS in human type 2 alveolar epithelial cells (A549 cells) through a pathway independent of pro-in¯ammatory cytokines. 59 There are therefore two pathways for iNOS induction in virus infections: cytokinedependent mechanisms, and direct upregulation by virus. More important, iNOS expression does not necessarily aid viral clearance in the infectious foci, but it is involved in virusinduced cytotoxicity regardless of the host's antiviral immune responses. NO has antimicrobial activity against bacteria, parasites, and fungi. 1±5 Antiviral effects of NO are also known for some types of virus, most typically DNA viruses such as murine poxvirus (ectromelia virus, EV) and herpes viruses, including HSV and Epstein-Barr virus (EBV), and some RNA viruses such as coxsackievirus. 31 ,60±63 EBV reactivation appears to be inhibited by NO via suppression of an immediate earlytransactivator gene. 61, 62 In contrast, coxsackievirus replication is suppressed by NO through inactivation of its viral cysteine protease by NO-dependent S-nitrosylation. 63 S-Nitrosylation of various proteins and sulfhydryl targets of pathogens is of great interest in view of the diverse functions of NO. 64±69 However, it remains ambiguous whether selective toxicity of NO for virus and virus-infected cells is brought about by NOdependent S-nitrosylation. In fact, considerable evidence shows redox regulation by S-nitrosylation of sulfhydrylcontaining proteins involved in inter-and intracellular signalling pathways, including neurotransmission, transcription, and apoptosis involving a caspase (thiol protease) cascade. 66 ,68±71 For example, NO and nitroso adducts of sulfhydryl compounds (nitrosothiols) have a potent antiapoptotic activity through S-nitrosylation or transnitrosylation reactions with caspases. Therefore, NO-induced S-nitrosylation not only affects viral replication but also may cause non-speci®c nitrosative stresses in host cells even without viral infections. Activity of NO against other viruses remains unclear, however. Recent reports suggest that NO has no appreciable antiviral effect on several types of viruses such as ortho-and paramyxovirus, murine vaccinia virus, coronavirus (mouse hepatitis virus, MHV), lymphocytic choriomeningitis virus (LCMV), murine encephalomyocarditis virus (EMCV), tickborn encephalitis virus (TBE-V), and others. 44±48,72,73 This lack of antiviral activity of NO has been proven in murine pneumotropic virus infections caused by in¯uenza and Sendai viruses in a series of our in vitro and in vivo studies (Akaike et al., unpublished observation). 48 Exposure of these viruses to biologically relevant concentrations of NO produces no appreciable reduction of viral growth in cultured cells in vitro. More important, antiviral host defence is not impaired by pharmacological interventions producing NOS inhibition or by genetic iNOS de®ciency of in mice infected with either in¯uenza virus or Sendai virus. 34, 48 Such NO inhibition and lack of NO biosynthesis, however, signi®cantly reduce the pathological consequences of various virus infections, including viral pneumonia in mice caused by in¯uenza virus, Sendai virus, and HSV-1; HSV-1-induced encephalitis in rats; EMCVinduced carditis and diabetes; and murine encephalitis induced by¯avivirus (Murray Valley encephalitis virus; TBE-V). 34,35,45,48,73±77 It is thus conceivable that NO is not entirely an antiviral molecule in various, if not all, virus infections. It has been suggested that NO affects the polarized Th1±Th2 response, causing a Th2-biased immunoregulatory balance, via a relatively speci®c suppressive effect on Th1 subpopulations. 78±80 Such NO-induced immunomodulation occurs during virus infection in mice, as revealed by recent studies of HSV-1 and in¯uenza virus infections. 45, 81 These biased Th2 responses are most clearly demonstrated by using iNOS ±/± mice, which show enhanced Th1 immune responses after these infections. 45, 81 It is believed that Th1 cells produce IL-2 and IFN-c, whereas production of IL-4 and IL-10 depends on Th2 cells. NO thus seems to downregulate the Th1-associated cytokine IFN-c, which is a major iNOS-inducing cytokine in virus infections as described above, and increases the Th2-associated IL-4 and IL-10 during virus infections in mice. However, the immunoregulatory effects of NO on Th1±Th2 balance are not commonly observed among different types of virus infections, and the pathological consequences of lack of iNOS are completely different in infections with different viruses. Liew's group showed that NO has a suppressive effect on the Th1 response in HSV-1 infection in the foot pad and the dorsal root ganglion in mice, as evidenced by increased IFN-c production and reduced levels of IL-4, and a subsequent elevation of anti-HSV-1 antibody in iNOS ±/± mice. 81 HSV-1 clearance is delayed in iNOS ±/± mice compared with the heterozygote mice, possibly because of impairment of the direct anti-HSV-1 activity of NO. In contrast, Karupiah et al. reported that the antiviral host defence in iNOS ±/± mice against in¯uenza virus is much greater than that in the wild-type mice, possibly because the NO-induced impairment of the Th1 response (particularly IFN-c production) is restored in iNOS ±/± mice. 45 The same group demonstrated that mouse poxvirus (EV) is susceptible to NO. Therefore, virus infection in iNOS ±/± mice is signi®cantly exacerbated, even though the Th1-dependent IFN-c response is enhanced by the disrupted iNOS gene. 82 Similarly, Lowenstein's group reported that the antiviral defence is eliminated in coxsackievirus-infected iNOS ±/± mice. 83, 84 However, in infections with vaccinia virus and corona virus (MHV), iNOS de®ciency affects neither antiviral host defence nor pathology of viral diseases. 44 Also, the antiviral immunological response against LCMV is unimpaired in mice lacking iNOS, although T-cell-mediated in¯ammation induced by LCMV is reduced. 46 Depending on the type of virus, Th cells, divided into two subsets (Th1 and Th2), protect hosts from intruding viral pathogens via virus-speci®c Th1 responses, potentiation of CD8 + cytotoxic T lymphocyte (CTL) activity, and B-cell proliferation. 85, 86 For non-cytopathic virus infections, CTLs rather than Th1±Th2 cells are important for antiviral host defenses. 85, 87 In contrast, some types of viruses, such as in¯uenza virus, can be eradicated without the help of CTLs. 41 A virus-speci®c Th1 response is more important for in¯uenza antiviral defence than the Th2 responses, because Th2 cells exacerbate pathological lung reactions in in¯uenza pneumonia. 88 In this context, Karupiah et al. reported that NO impairs the anti-in¯uenza virus response of the host by suppressing Th1-dependent IFN-c induction and tipping the Th1±Th2 balance toward Th2 domination. 45 However, it has now been demonstrated that IFN-c, a Th1-dependent cytokine, is eventually inef®cient in clearance of in¯uenza virus from infectious foci, 42 and even IL-4, induced by Th2 responses, possesses antiviral activity against murine paramyxovirus (Sendai virus). 89 Our recent experiments using iNOS ±/± mice indicate that clearance of virus from lungs infected with either in¯uenza virus or Sendai virus is not affected by a lack of iNOS expression (Akaike et al., unpublished observation). 48 In fact, iNOS ±/± mice recuperate from viral pneumonia much better than do wild-type animals, because of reduced levels of oxidative stress in virus-infected tissues. 48 Therefore, not only NO-induced Th1 suppression, but also NO-induced oxidative injury may, be attributable to pathogenesis of infection with certain viruses that are resistant to the direct antiviral actions of NO. In addition, NO seems to have profound immunosuppressive and immunopathological effects, most typically in Mycobacterium avium and Salmonella typhimurium infections, 90 ,91 which may be due to NO-induced cytotoxic effects on immune effector cells such as macrophages. Similar immunosuppression by NO is clearly demonstrated with vaccinia virus-infected murine macrophages, which show a loss of antiviral activity because of inhibition of IFN-a/b production by NO. 72 Thus, NO has complex roles in immunological host responses against viruses. The mechanism of pathogenesis of virus infection is mediated by the following three classes of biological events affected by NO: 1 Direct antiviral effects of NO that may contribute to innate resistance of hosts to viruses: e.g. coxsackievirus and EV appear to be potentially susceptible to NO. 2 Effects of NO on antiviral defence mediated by polarized Th1±Th2 immunological reactions of hosts: if the Th1 response is critical for viral clearance, NO may impair antiviral responses by suppressing Th1 functions. 3 Contribution of NO-induced oxidative stress: NO-induced cytotoxicity via oxidative injury may cause not only immunosuppression and immunopathology, but also cellular and organ dysfunctions (detailed molecular mechanisms are described in the following section). NO itself is an inert radical and much less reactive compared with other naturally occurring oxygen and alkyl radicals. 7±9,11,12 Of the complex chemistry of NO, the most important and biologically relevant reaction is formation of ONOO ± via a very rapid radical coupling with O 2 ± (NO+O 2 ± p ONOO ± : k=6 . 7r10 9 M x1 s x1 ). 7±9,11,12 Although NO can function as an antioxidant, particularly in lipid peroxidation, 9 it also has indirect pro-oxidant activity after conversion to a strong oxidant and a potent nitrating agent (ONOO ± ) causing oxidative stress. 8 In addition, although NO and nitrosothiols show strong anti-apoptotic effects as described above, 67±71 ONOO ± induces apoptosis, possibly via mitochondrial damage leading to cytochrome c release. 10, 92 NO chemistry in biological systems is shown schematically in Fig. 2 . As mentioned above, the reaction between NO and O 2 ± takes place in virus-infected in¯ammatory tissues, leading to formation of ONOO ± . Immunohistochemical analysis with antinitrotyrosine antibody shows positive staining in macrophages and neutrophils in®ltrating the alveoli and interstitial tissues, as well as in in¯ammatory intra-alveolar exudate in virus-infected lung, 34 which provides indirect indication of ONOO ± generation during virus infection. ONOO ± may cause various pathological events in virus infections, such as host cell apoptosis and necrosis. It may be also involved in NO-induced suppressive effects on macrophages, as described in earlier sections. In addition, we recently found that ONOO ± activates matrix metalloproteinases (MMPs), which are involved in extracellular tissue damage and remodelling. 93 Accordingly, oxidative tissue injury in virus-infected lung may be mediated by ONOO ±--induced MMP activation. In fact, remarkable improvements in pathological condition in the lung and in survival rate of virus-infected mice were observed with L-NMMA, and with the O 2 ± scavenger SOD and the XO inhibitor allopurinol as well. 34, 38 Furthermore, a therapeutic effect on in¯uenza pathogenesis was found with a selenium-containing organic compound, ebselen (unpublished observation), which shows potent ONOO ± -scavenging action. 94 The bene®cial effects of these pharmacological interventions indicate that ONOO ± could be an important molecular species in the pathogenesis of in¯uenza virus-induced pneumonia in mice. The pathological effects of NO and O 2 ± in virus infection mentioned above are in clear contrast to their bene®cial antimicrobial effects in bacterial and fungal infections. 1±5 Antibacterial host defence mediated by NO is typi®ed in a murine salmonellosis model. 5 When Salmonella typhimurium is injected into mice, effective bacterial growth is observed in the liver. Overproduction of NO in the Salmonella-infected liver parallels the bacterial growth as identi®ed by ESR spectroscopy. Here, the consequence of suppression of NO or O 2 ± is, however, completely opposite to the effect in the in¯uenza model. Treatment of murine salmonellosis with either L-NMMA or allopurinol results in a greater mortality rate as well as increased bacterial growth. 5 It is thus suggested that NO and O 2 ± , and possibly ONOO ± , function as endogenous antimicrobial agents. The opposite effects of NO in different infectious diseases may occur as a result of different modes of microbial replication and invasion of host tissues. Most bacteria can be con®ned to areas of septic foci, which are most typically abscesses or granulomas in the tissues. Therefore, chemically reactive NO, O 2 ± , and ONOO ± can affect bacteria relatively selectively; the surrounding normal tissue remains intact. In virus infections, in contrast, NO and ONOO ± , which are primitive host-defence molecules, will cause non-speci®c oxidative damage in virus-infected tissue, leading to various pathological events, because virus cannot be con®ned to limited areas by the non-speci®c host defence mediated by phagocytes and their mediators NO and O 2 ± . 15±17 Among the NO-induced pathological effects, the mutagenic potential of NO for microbial pathogens is highly intriguing. It was previously shown that human leucocytes producing O 2 ± , but not leucocytes from patients with chronic granulomatous disease, are mutagenic for S. typhimurium TA100. 95 ONOO ± has mutagenic effects on prokaryotic DNA, possibly via nitration of guanine residues of DNA. A typical base substitution caused by ONOO ± is G to T transversion, which is an indirect result of depurination of nitroguanine in DNA. 96, 97 A recent study documented that a high output of NO induced mutations in an endogenous hypoxanthine± guanine phosphoribosyltransferase (hprt) gene of murine macrophages expressing iNOS. 98 As described in earlier sections, overproduction of NO and oxygen radicals appears to be a common phenomenon in various infections. The resultant reactive molecular species such as ONOO ± non-selectively affect the host's cells and tissues. Obviously, such host defence effectors are originally produced to kill the intruding pathogens, which then suffer oxidative stress because of the host. It may therefore be logical to assume that mutagenesis of various pathogens occurs during infections in biological systems as a result of host defence. However, only a few reports explore a possible association between oxidative stress and viral mutation. Beck et al. showed that the pathogenicity of coxsackievirus B3 is strongly potentiated in vivo in mice fed a selenium-de®cient diet. 99 More important, an avirulent strain of the virus is converted to a potent cardiotoxic variant during infection in seleniumdepleted animals. The de®ciency of selenium may result in an ineffective antioxidant system, e.g. low levels of glutathione peroxidase. Results of similar studies extended to animals de®cient in vitamin E and glutathione peroxidase suggest that oxidative stress facilitates selection and generation of virulent mutants. 100 More speci®cally, the impaired immunological viral clearance related to oxidative stress may cause increased survival of heterogeneous mutants, resulting in selection of highly pathogenic variants of coxsackievirus. In addition, our recent study veri®es for the ®rst time that oxidative stress induced by a high output of NO accelerates mutation of RNA virus. 48 By using a recombinant RNA virus (Sendai) containing a marker gene (green¯uorescent protein, GFP) for genetic mutation and iNOS knockout mice, we clearly showed that oxidative stress induced by NO in wild-type mice in vivo remarkably increases and accelerates viral mutation rates compared with the situation in iNOS-de®cient mice (Fig. 3) . This process of accelerated mutation may occur in other virus infections in vivo. For example, NO-induced oxidative stress may cause greater heterogeneity of variants of RNA viruses including HIV and in¯uenza virus, leading to rapid viral evolution under selective pressure and to production of drug-resistant and immunologically tolerant and cell tropism-altered mutants (Fig. 4) . We now know that NO and O 2 ± , and hence ONOO ± and other reactive molecular species such as NO 2 , ClO ± , and H 2 O 2 , are generated universally as a result of host responses during infections. Therefore, we may expect such chemical mutagenesis in other DNA viruses, bacteria, and even host cells, although it may not be as effective as that in single-strand RNA viruses. Biological consequences of NO generation and implications for pathogenesis of virus infections are discussed by illustrating NO-modulated non-speci®c and virus-speci®c immune responses of the hosts. Free radicals are produced primarily as effector molecules of the host defence response. Their biological effects, however, are not necessarily bene®cial to the infected host. Understanding of the pathophysiological func-tions of NO and oxygen radicals will provide profound insights into many aspects of infectious diseases. Speci®c amino acid (L-arginine) requirement for microbiostatic activity of murine macrophages Role of nitric oxide synthesis in macrophage antimicrobial activity Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis Role of nitric oxide in parasitic infections Induction of nitric oxide synthesis and xanthine oxidase and their role in the antimicrobial mechanism against Salmonella typhimurium in mice Active oxygen species and the functions of phagocytic leukocytes Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide Nitric oxide, superoxide and peroxynitrite: The good, bad, and the ugly Nitric oxide regulation of tissue free radical injury Induction of nitric oxidedependent apoptosis in motor neurons by zinc-de®cient superoxide dismutase Tyrosine nitration by peroxynitrite formed from nitric oxide and superoxide generated by xanthine oxidase Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite Molecular pathogenesis of in¯uenza virus pneumonia: Impacts of proteases, kinins, and oxygen radicals derived from hosts Oxygen free radicals as pathogenic molecules in viral diseases Free radicals in viral pathogenesis: molecular mechanisms involving superoxide and NO Nitric oxide in in¯uenza Pathophysiological effects of high-output production of nitric oxide Inducible nitric oxide synthase: what difference does it make? The L-arginine-nitric oxide pathway Mammalian nitric oxide synthase Pronounced enhancement of NO-dependent antimicrobial action by an NO-oxidizing agent, imidazolineoxyl Noxide Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model Helicobacter pylori urease suppresses bactericidal activity of peroxynitrite via carbon dioxide production Identi®cation of nitric oxide synthase as a protective locus against tuberculosis Phenotype of mice and macrophages de®cient in both phagocyte oxidase and inducible nitric oxide synthase Reactive nitrogen intermediates and the pathogensis of Salmonella and mycobacteria Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases Severity of neurological signs and degree of in¯ammatory lesions in the brains of the rats with Borna disease correlate with the induction of nitric oxide synthase Inhibition of viral replication by interferon-cinduced nitric oxide synthase Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackie virus B3 Pathogenesis of in¯uenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats Regulation of nitric oxide synthase activity in human immuno-de®ciency virus type 1 (HSV-1) -infected monocytes: implications for HIV-associated neurological disease Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation Dependence on O 2 ± generation by xanthine oxidase of pathogenesis of in¯uenza virus infection in mice Poliovirus-speci®c CD4 + Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor Site-restricted persistent cytomegalovirus infection after selective long-term deletion of CD4 + T lymphocytes Clearance of in¯uenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8 + T cells Response to in¯uenza infection in mice with a targeted disruption in the interferon c gene The cytotoxic Tlymphocyte response to Sendai virus is unimpaired in the absence of gamma interferon IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-c and nitric oxide synthetase 2 Rapid interferon gamma-dependent clearance of in¯uenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-de®cient mice Inducible nitric-oxide synthase plays a minimal role in lymphocytic choriomeningitis virus-induced, T cell-mediated protective immunity and immunopathology Coronavirus-induced demyelination occurs in the absence of inducible nitric oxide synthase Viral mutation accelerated by nitric oxide production during infection in vivo Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-c in murine macrophages Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor b Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages Arginase induction by suppression of nitric oxide synthesis (IL-4, IL-10 and PGE 2 ) in murine bone marrow-derived macrophages Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line Coinduction of nitric oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide Mechanisms and structural determinants of HIV-1 coat protein, gp41-induced neurotoxicity Human immunode®ciency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production on astrocytes: astrocytic NO as a possible mediator of neuronal damage in acquired immunode®ciency syndrome Human immunode®ciency virus infection, inducible nitric oxide synthase expression, and microglial activation: pathogenetic relationship to the acquired immunode®ciency syndrome dementia complex Intensity of myocardial expression of inducible nitric oxide synthase in¯uences the clinical course of human immunode®ciency virus-associated cardiomyopathy Respiratory syncytial virus infection of human respiratory epithelial cells enhances inducible nitric oxide synthase gene expression Evidence for an antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein±Barr virus reactivation Nitric oxide down-regulates Epstein±Barr virus reactivation in epithelial cell lines An antiviral mechanism of nitric oxide: inhibition of a viral proteinase Biochemistry of nitric oxide and its redox-activated forms Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways An essential role of free radicals and derived species in signal transduction Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo Mechanisms of biological S-nitrosation and its measurement Protective effect of S-nitrosylated a 1 -protease inhibitor on hepatic ischemiareperfusion injury Nitric oxide inhibits CPP. 32-like activity under redox regulation Fas-induced caspase denitrosylation Inhibitory activity of constitutive nitric oxide on the expression of alpha/beta interferon genes in murine peritoneal macrophages Nitric oxide and viral infection: no antiviral activity against a¯avivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo Suppression of herpes simplex virus type 1 (HSV-1) -induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2) Treatment of experimental viral myocarditis with interleukin-10 Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine kinase signalling pathway and subsequent suppression of nitric oxide production in macrophages The severity of Murray Valley encephalitis in mice is linked to neutrophil in®ltration and inducible nitric oxide synthase activity in the central nervous system Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells Altered immune responses in mice lacking inducible nitric oxide synthase Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses Identi®cation of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection Inducible nitric oxide synthase protection against coxsackievirus pancreatitis The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis Immunology taught by viruses Different rules govern help for cytotoxic T cells and B cells A case for cytokines as effector molecules in the resolution of virus infection In¯uenza virus-speci®c CD4 + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection Modi®cation of the Sendai virus-speci®c antibody and CD8 + T-cell responses in mice homozygous for disruption of the interleukin-4 gene Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro Nitric oxide induces tyrosine nitration and release of cytochrome c preceding an increase of mitochondrial transmembrane potential in macrophages Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism of procollagenase activation involving nitric oxide The reaction of ebselen with peroxynitrite Mutation caused by human phagocytes Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells Mutagenesis associated with nitric oxide production in macrophages Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-de®cient mice results in selection of identical virulent isolates Glutathione peroxidase protects mice from viral-induced myocarditis We thank Ms Judith B. Gandy for editorial preparation of the manuscript. This work is supported by a Grant-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan, and a grant from the Ministry of Health and Welfare of Japan.